The Global Leader in Business & Technology News: CEOWORLD Magazine|Wednesday, June 19, 2013
You are here: Home » AMLN
  • Follow Us!
EDITOR'S PICKS

AMLN

Why Orexigen Therapeutics (OREX) shares are surging- Contrave?

Orexigen Therapeutics (OREX), a biopharmaceutical company a biopharmaceutical company focused on the treatment of obesity was up 18.06% as company announced its conference call on Friday, June 3, 2011 before the markets opens. Investors are guessing that the company will have something positive to say about its diet pill Contrave, which was denied approval by the Food and Drug ...Full Article

CEOWORLD Daily Business Roundup- JNJ, CHK, AMD, T, AXP, AAPL, INTC, JPM, GOOG, LLY, CSCO…

Johnson & Johnson Inc. (JNJ) is in talks to buy Swiss medical-device maker Synthes Inc. $20 billion. Charles Schwab (SCHW) a discount broker, declared boosted profit for the first ...Full Article

Analyst Upgrades and Downgrades BMY, SCCO, SAAS, KMT, HAL, LULU, PCYC, SGI, BTE, ULTI, LMNX, MJN, MWA, EDU, DNDN…

Aeropostale ] upgraded to Neutral from Underweight, $31 target, at Piper Jaffray Amylin Pharma ] initiated as Buy at Jefferies Dendreon ] initiated as Outperform at RW Baird Halliburton ...Full Article

Analyst Upgrades and Downgrades DIS, KO, BA, BBT, FDX, RCL, CBEY, DFG, FITB, MTB, MSG, SBX…

Anadarko Petroleum ] reiterated Outperform, price target raised to $90 from $75, at FBR… BB&T ] upgraded to Outperform from Market Perform at Bernstein… Big Lots ] maintained Overweight, ...Full Article

Analyst Upgrades and Downgrades AXP, CSCO, AA, WAL, TXN, HSY, CSUN, CLR, SPWRA…

Abercrombie ] reiterated Overweight, target raised to $44 from $40, at Piper Jaffray… Alcoa ] upgraded to Market Perform, $15 target, at BMO Capital… Almost Family ] downgraded to ...Full Article

FDA Warns Bayer, Eli Lilly, Cephalon and Amylin Pharmaceuticals about Faulty Ads- lesson for Drug Companies

FDA sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The U.S. Food and Drug Administration mentioned that Bayer ...Full Article